2 completed, 2 recruiting, 2 unknown. 4 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 2, Completed 1, Unknown 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Hymecromone: new trials by email Literature Review of Hymecromone trials Research Report on Hymecromone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| H01 in Adults With Interstitial Lung Disease (The SOLIS Study) hymecromone - Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis | Phase 2 | Recruiting | National Institute of Environmental Health Sciences (NIEHS) | 37 | 2025-05-05 | 2026-07-28 |
| Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis. Hymecromone - Primary Sclerosing Cholangitis | Phase 2 | Recruiting | Aparna Goel | 24 | 2023-05-10 | 2025-06-13 |
| A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19. Hymecromone tablets, Placebo - COVID-19 | Not applicable | Unknown | Shanghai Zhongshan Hospital | 304 | 2022-05-23 | 2022-06-09 |
| Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study). Hymecromone (H01), Placebo - Pulmonary Hypertension | Phase 2 | Completed | Stanford University | 17 | 2022-04-01 | 2024-11-26 |
| A Study of Oral Hymecromone and Hyaluronan Synthesis hymecromone - Healthy, Respiratory Disease | Phase 1 | Completed | Paul Bollyky | 12 | 2020-12-01 | 2021-06-16 |
| 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV 4-Methylumbelliferone (Heparvit®) - Chronic Hepatitis C, Chronic Hepatitis B | Phase 2 | Unknown | MTmedical Institute of Health | 160 | 2005-09-01 | 2006-09-11 |
Acquired Immunodeficiency Syndrome (1) · COVID-19 (1) · Cholangitis, Sclerosing (1) · Hepatitis (1) · Hepatitis B (1) · Hepatitis B, Chronic (1) · Hepatitis C (1) · Hepatitis C, Chronic (1) · Hypertension, Pulmonary (1) · Idiopathic Pulmonary Fibrosis (1) · Lung Diseases (1) · Lung Diseases, Interstitial (1) · Pulmonary Fibrosis (1) · Respiration Disorders (1)
Aparna Goel (1) · MTmedical Institute of Health (1) · National Institute of Environmental Health Sciences (NIEHS) (1) · Paul Bollyky (1) · Shanghai Zhongshan Hospital (1) · Stanford University (1)
United States (5) · China (1)
Anastacio M Hoyumpa, Prof. M.D. (1) · Aparna Goel, MD (1) · Charles T Leach, Prof. M.D. (1) · Dubravko Pavlin, PhD (1) · Hao Fang (1) · Leina Alrabadi, MD (1) · Paul Bollyky, MD (1) · Stavros Garantziotis, M.D. (1)